Population-Level Analysis of Appropriateness of End-of-Life Care for Children with Neurologic Conditions

J Pediatr. 2023 Apr:255:128-136.e8. doi: 10.1016/j.jpeds.2022.10.037. Epub 2022 Nov 10.

Abstract

Objective: The objective of this study was to measure the appropriateness of end-of-life care for children who died with neurologic conditions.

Study design: Based on linked routinely collected databases, we conducted a population-level decedent retrospective cohort study of children with neurologic conditions who died in Belgium between 2010 and 2017. We measured a set of 22 face-validated quality indicators. The set concerns 12 indicators of potentially appropriate end-of-life care (eg, specialized comfort medication, physician contact, continuous care) and 10 indicators of potentially inappropriate end-of-life care (eg, diagnostic tests, phlebotomy). We performed ANOVA for predictors (age, sex, disease category, nationality, having siblings, year of death) for scales of appropriate and inappropriate care.

Results: Between 2010 and 2017, 139 children with neurologic conditions died in Belgium. For potentially appropriate care, in the last 30 days, 76% of children received clinical care, 55% had continuous care relationships, 17% had contact with a general physician, 8% of children received specialized comfort medication, and 14% received care from a palliative care team. For potentially inappropriate care, in the last 14 days, 45% had blood drawn and 27% were admitted to intensive care unit.

Conclusions: Our study found indications of appropriate as well as inappropriate end-of-life care for children who died with neurologic conditions. These findings reveal a substantial margin for potential quality improvement, in regard to palliative care provision, multidisciplinary care, financial support, specialized comfort medication, clinical follow-up, general physician contact, diagnostics, and blood drawing.

Keywords: cohort decedent study; indicators; quality of care.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Belgium
  • Child
  • Humans
  • Nervous System Diseases* / therapy
  • Palliative Care
  • Retrospective Studies
  • Terminal Care*